Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: an updated instrumental variable meta-analysis
Menglan Pang, Ling Zhu, Audrey Gabelle, Arie R. Gafson, Robert W Platt, James E Galvin, Pierre Krolak-Salmon, Ivana Rubino, Carl de Moor, Shibeshih Belachew, Changyu Shen
doi: https://doi.org/10.1101/2022.04.01.22273253
Menglan Pang
1Biogen Digital Health, Biogen, Cambridge, MA, USA
7Biogen, Cambridge, MA, USA
PhDLing Zhu
1Biogen Digital Health, Biogen, Cambridge, MA, USA
7Biogen, Cambridge, MA, USA
PhDAudrey Gabelle
1Biogen Digital Health, Biogen, Cambridge, MA, USA
7Biogen, Cambridge, MA, USA
MD, PhDArie R. Gafson
1Biogen Digital Health, Biogen, Cambridge, MA, USA
7Biogen, Cambridge, MA, USA
MD, PhDRobert W Platt
2McGill University, Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, QC, Canada
PhDJames E Galvin
3Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA
4Comprehensive Center for Brain Health, Department of Neurology, University of Miami Miller School of Medicine, Boca Raton, FL, USA
MD, MPHPierre Krolak-Salmon
5Clinical and Research Memory Center of Lyon (CMRR Lyon), Lyon Institute For Aging, University hospital of Lyon (Hospices Civils de Lyon), Lyon, France
6Neuroscience Research Centre of Lyon, Inserm 1048, CNRS 5292, Lyon, France
MD, PhDIvana Rubino
7Biogen, Cambridge, MA, USA
PhDCarl de Moor
1Biogen Digital Health, Biogen, Cambridge, MA, USA
7Biogen, Cambridge, MA, USA
PhDShibeshih Belachew
1Biogen Digital Health, Biogen, Cambridge, MA, USA
7Biogen, Cambridge, MA, USA
MD, PhDChangyu Shen
1Biogen Digital Health, Biogen, Cambridge, MA, USA
7Biogen, Cambridge, MA, USA
PhDData Availability
All data produced in the present work are contained in the manuscript
Posted April 05, 2022.
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: an updated instrumental variable meta-analysis
Menglan Pang, Ling Zhu, Audrey Gabelle, Arie R. Gafson, Robert W Platt, James E Galvin, Pierre Krolak-Salmon, Ivana Rubino, Carl de Moor, Shibeshih Belachew, Changyu Shen
medRxiv 2022.04.01.22273253; doi: https://doi.org/10.1101/2022.04.01.22273253
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: an updated instrumental variable meta-analysis
Menglan Pang, Ling Zhu, Audrey Gabelle, Arie R. Gafson, Robert W Platt, James E Galvin, Pierre Krolak-Salmon, Ivana Rubino, Carl de Moor, Shibeshih Belachew, Changyu Shen
medRxiv 2022.04.01.22273253; doi: https://doi.org/10.1101/2022.04.01.22273253
Subject Area
Subject Areas
- Addiction Medicine (365)
- Allergy and Immunology (685)
- Anesthesia (183)
- Cardiovascular Medicine (2724)
- Dermatology (234)
- Emergency Medicine (411)
- Epidemiology (12376)
- Forensic Medicine (10)
- Gastroenterology (783)
- Genetic and Genomic Medicine (4232)
- Geriatric Medicine (394)
- Health Economics (698)
- Health Informatics (2731)
- Health Policy (1014)
- Hematology (369)
- HIV/AIDS (874)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (450)
- Neurology (4009)
- Nursing (216)
- Nutrition (594)
- Oncology (2112)
- Ophthalmology (602)
- Orthopedics (250)
- Otolaryngology (310)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1145)
- Primary Care Research (465)
- Public and Global Health (6629)
- Radiology and Imaging (1440)
- Respiratory Medicine (883)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (461)
- Toxicology (57)
- Transplantation (192)
- Urology (171)